Literature DB >> 35119522

Clinical effect of rectus sheath block compared to intrathecal morphine injection for minimally invasive colorectal cancer surgery: a propensity score-matched study.

Abdullah Al-Sawat1, Chul Seung Lee2, Sang Hyun Hong3, Jung-Woo Shim3, Min Suk Chae3, Seung-Rim Han2, Jung Hoon Bae2, In Kyu Lee2, Dosang Lee2, Yoon Suk Lee4.   

Abstract

PURPOSE: To evaluate the postoperative outcomes of a multimodal perioperative pain management protocol with rectus sheath blocks (RSBs) or intrathecal morphine (ITM) injection for minimally invasive colorectal cancer surgery.
METHODS: A total of 112 patients underwent minimally invasive colorectal surgery. Forty-one patients underwent RSB (group 1), whereas 71 patients underwent ITM (group 2) in addition to multimodal pain management using enhanced recovery after the surgery protocol. To adjust for the baseline differences and selection bias, baseline characteristics and postoperative outcomes were compared using propensity score matching.
RESULTS: Forty patients were evaluated in each group. There was no significant difference in the length of hospital stay between the two groups. According to the Comprehensive Complication Index (CCI) score, the postoperative complication rate was significantly lower in the RSB group (3.0 ± 7.8) than in the ITM group (8.1 ± 10.9; p = 0.016). During the first 24 h after surgery, the median postoperative visual analog scale score was significantly higher in the RSB group than in the ITM group (2.0 ± 1.1 vs. 1.5 ± 1.2; p = 0.048). Postoperative morphine use was also significantly higher in the RSB group than in the ITM group in the first 24 h (23.7 ± 19.8 vs 11.6 ± 15.6%; p = 0.003) and 48 h (16.9 ± 24.8 vs. 7.5 ± 11.9; p = 0.036) after surgery. Significant urinary retention occurred after the in the RSB and ITM groups (5% vs. 45%; p < 0.001).
CONCLUSION: Although the RSB group had higher morphine use during the first 48 h after surgery, the length of hospital stay remained the same and the complications were less in terms of the CCI score. Thus, transperitoneal RSB is a safe and feasible approach for postoperative pain management following minimally invasive procedures.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Length of stay; Morphine; Pain management; Postoperative period; Urinary retention

Mesh:

Substances:

Year:  2022        PMID: 35119522     DOI: 10.1007/s00384-022-04094-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  5 in total

1.  [Ultrasound-guided rectus sheath blockade is a safe and accurate method for emergency ileostomy for patients with coagulopathy].

Authors:  Yoshimune Osaka; Masanori Kashiwagi; Yukio Nagatsuka; Sakurako Miwa
Journal:  Masui       Date:  2011-10

2.  The safety and efficacy of intrathecal opioid analgesia for acute postoperative pain: seven years' experience with 5969 surgical patients at Indiana University Hospital.

Authors:  K H Gwirtz; J V Young; R S Byers; C Alley; K Levin; S G Walker; R K Stoelting
Journal:  Anesth Analg       Date:  1999-03       Impact factor: 5.108

3.  Comparison of 0.25% Ropivacaine for Intraperitoneal Instillation v/s Rectus Sheath Block for Postoperative Pain Relief Following Laparoscopic Cholecystectomy: A Prospective Study.

Authors:  Monika Gupta; Udita Naithani; Geeta Singariya; Sunanda Gupta
Journal:  J Clin Diagn Res       Date:  2016-08-01

4.  Effects of Intraperitoneal Local Anaesthetics Bupivacaine and Ropivacaine versus Placebo on Postoperative Pain after Laparoscopic Cholecystectomy: A Randomised Double Blind Study.

Authors:  Neha T Das; Charulata Deshpande
Journal:  J Clin Diagn Res       Date:  2017-07-01

5.  Comprehensive Complication Index Predicts Cancer-Specific Survival of Patients with Postoperative Complications after Curative Resection of Gastric Cancer.

Authors:  Ru-Hong Tu; Jian-Xian Lin; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Chao-Hui Zheng; Chang-Ming Huang
Journal:  Gastroenterol Res Pract       Date:  2018-11-19       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.